oncologyhigh engagement
Oncology trials keep pushing immunotherapy and precision medicine forward
Multiple recruiting cancer studies highlight ongoing clinical development in immunotherapy, precision oncology, and niche tumor types, including rare genitourinary tumors, non-small cell lung cancer, solid tumors screened by genetic testing, and immunotherapy side-effect monitoring. This is relevant to healthtech operators building trial infrastructure, oncology workflows, data platforms, and evidence-generation tools.
Draft a post from this →clinical-trialshigh engagement
Metabolic drug trials keep stacking up across chronic disease care
A cluster of late-stage and early-stage clinical trials shows continued momentum in metabolic disease and cardiometabolic indications, including type 2 diabetes with cortisol excess, obesity-linked sleep apnea, and obesity with established atherosclerotic cardiovascular disease. For healthtech founders, this underscores the expanding software, diagnostics, and patient-management opportunities around chronic disease care pathways.
Draft a post from this →pediatricsmedium engagement
Hospital and home care trials spotlight new digital workflow openings
Recent trials in pediatric asthma home monitoring, preterm infant microbiome research, and ICU/post-surgical acid suppression reflect the steady growth of hospital-based and home-based care studies. These signals map to software-enabled care delivery, remote monitoring, and data collection workflows that matter for healthtech founders selling into providers and researchers.
Draft a post from this →neurologymedium engagement
Migraine and pain studies keep advancing specialty care
Drug development activity continues in migraine and postoperative pain management, with a phase 3 migraine trial and a phase 4 intraoperative methadone study in head and neck cancer patients. For healthtech founders, these studies reinforce the importance of patient-reported outcomes, digital symptom tracking, and specialty care platforms.
Draft a post from this →health-data-infrastructuremedium engagement
Health data infrastructure and AI tooling keep drawing attention
NIH funding for BioData Catalyst data management, along with attention on Claude Code for health data work and Nuance Communications, points to ongoing investment in health data infrastructure, AI-assisted workflows, and speech or clinical documentation tooling. This is highly relevant to software-enabled healthcare businesses building core data rails and productivity tools.
Draft a post from this →